相关实验视频

Updated: May 6, 2026

Analysis of Human Natural Killer Cell Metabolism

Analysis of Human Natural Killer Cell Metabolism

Published on: June 22, 2020

通过NRH补充促进NAD+增强提高了EOC的治疗效率在体外

Kevin J Lee¹, Sagar Chokshi¹, Tanvi Joshi¹

¹USA Health Mitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, USA.

International journal of molecular sciences

|February 26, 2025

概括

二氨基胺基核酸 (NRH) 增加细胞NAD+并显示在卵巢癌细胞中显著的细胞毒性. NRH增强了卡博普拉丁和奥拉帕里布等常见癌症疗法的有效性,表明其作为治疗增强剂的潜力.

科学领域:

生物化学和分子生物学
在瘤学瘤学.
细胞的新陈代谢

背景情况:

尼古丁胺胺二核酸 (NAD+) 是细胞功能的关键辅因子,包括新陈代谢和DNA修复.
表皮卵巢癌 (EOC) 的特征是细胞代谢发生变化和DNA修复受损,影响NAD+水平.
降低NAD+前体的二氨基胺核酸 (NRH) 显示出可能比传统前体更有效地提高NAD+水平.

研究的目的:

在EOC细胞系中研究NRH补充的细胞毒性作用.
评估NRH在EOC中提高标准化疗剂疗效的潜力.
探索NRH诱导的细胞毒性及其对细胞能量代谢的影响的潜在机制.

主要方法:

用NRH和尼古丁酸 (NA) 对EOC细胞系 (OVCAR8,ES2,SKOV3) 的治疗.
在NRH补充剂后评估细胞细胞毒性和NAD(P) H水平.
对NRH对卡博普拉丁,帕克利塔克塞尔和奥拉巴里布 (PARP抑制剂) 细胞毒性的影响的评估.

主要成果:

补充NRH在EOC细胞中诱导了显著的细胞毒性 (~40%),而NA的影响很小.
NRH增加了细胞内NAD和P) H水平,在细胞系中具有不同程度.
NRH增强了OVCAR8细胞中的卡博普拉丁和帕克利塔塞尔的细胞毒性,以及OVCAR8和SKOV3细胞中的奥拉帕里布,影响了线粒体呼吸.

结论:

补充NRH是一种可行的策略,可以利用EOC中的NAD+生物能量表型,从而潜在地增强治疗反应.
NRH与标准疗法表现出协同性细胞毒性,这表明它在克服治疗耐药性方面发挥了作用.
NAD+代谢组可以作为指导涉及NRH的EOC治疗决策的生物标志物.

关键词:

它们是NAD+NAD+NAD.在NRH中,NRH是NRH.在 PARP 抑制剂.这就是Olaparib.卵巢癌是发生在卵巢的癌症.

更多相关视频

In Vitro Cellular Activity Evaluation of the Nanoemulsion Vaccine Adjuvant Ophiopogonin D

In Vitro Cellular Activity Evaluation of the Nanoemulsion Vaccine Adjuvant Ophiopogonin D

Published on: December 9, 2022

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination

Published on: February 23, 2024

相关概念视频

Nuclear Overhauser Enhancement (NOE)

Nuclear Overhauser Enhancement (NOE)

Irradiation of a spin-active nucleus causes an increase or decrease in the signal intensity of neighboring nuclei that are not necessarily chemically bonded or involved in J-coupling. This phenomenon, called the nuclear Overhauser enhancement (NOE), results from through-space interactions between the nuclear spins. The NOE effect decreases with increasing internuclear distance and is generally not observed beyond 4 angstroms. In NOE, dipole-dipole interactions between neighboring spin-active...

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...